1. Home
  2. TFSL vs GH Comparison

TFSL vs GH Comparison

Compare TFSL & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFSL
  • GH
  • Stock Information
  • Founded
  • TFSL 1938
  • GH 2011
  • Country
  • TFSL United States
  • GH United States
  • Employees
  • TFSL N/A
  • GH N/A
  • Industry
  • TFSL Savings Institutions
  • GH Medical Specialities
  • Sector
  • TFSL Finance
  • GH Health Care
  • Exchange
  • TFSL Nasdaq
  • GH Nasdaq
  • Market Cap
  • TFSL 3.8B
  • GH 3.0B
  • IPO Year
  • TFSL 2007
  • GH 2018
  • Fundamental
  • Price
  • TFSL $13.24
  • GH $25.31
  • Analyst Decision
  • TFSL Hold
  • GH Strong Buy
  • Analyst Count
  • TFSL 2
  • GH 17
  • Target Price
  • TFSL $14.00
  • GH $39.31
  • AVG Volume (30 Days)
  • TFSL 195.1K
  • GH 2.4M
  • Earning Date
  • TFSL 10-24-2024
  • GH 11-04-2024
  • Dividend Yield
  • TFSL 8.52%
  • GH N/A
  • EPS Growth
  • TFSL N/A
  • GH N/A
  • EPS
  • TFSL 0.28
  • GH N/A
  • Revenue
  • TFSL $305,488,000.00
  • GH $643,810,000.00
  • Revenue This Year
  • TFSL N/A
  • GH $27.01
  • Revenue Next Year
  • TFSL N/A
  • GH $18.30
  • P/E Ratio
  • TFSL $46.96
  • GH N/A
  • Revenue Growth
  • TFSL N/A
  • GH 26.20
  • 52 Week Low
  • TFSL $10.97
  • GH $15.81
  • 52 Week High
  • TFSL $15.25
  • GH $37.04
  • Technical
  • Relative Strength Index (RSI)
  • TFSL 51.64
  • GH 41.83
  • Support Level
  • TFSL $12.95
  • GH $23.07
  • Resistance Level
  • TFSL $13.29
  • GH $27.13
  • Average True Range (ATR)
  • TFSL 0.24
  • GH 1.24
  • MACD
  • TFSL -0.01
  • GH 0.19
  • Stochastic Oscillator
  • TFSL 62.25
  • GH 43.35

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

About GH Guardant Health Inc.

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: